Register Login

TWILIGHT Study: Discontinue Aspirin

Click or tap here to read and hear about the TWILIGHT trial outcomes that illustrate how three months after cardiac catheterization (PCI), aspirin may be discontinued. The trial showed that ticagrelor monotherapy was equally effective and safer than tacagrelor plus aspirin.

Comments (0)
Antiplatelet Therapy

No comments here.

Leave a Reply